Selasa, 14 Juli 2026 - 14:27 WIB

Find and Follow Us

Global Markets

IHSG 6,080.59 +0.71%

S&P 500 7,515.34 -0.79%

NASDAQ 25,873.18 -1.55%

Dow Jones 52,498.64 -0.26%

FTSE 100 10,491.34 -0.07%

CAC 40 8,317.39 -0.57%

Nikkei 225 67,743.50 +0.74%

Hang Seng 24,406.48 +0.80%

Shanghai 3,967.13 +1.36%

KOSPI 6,856.83 +0.73%

STI 5,499.83 +0.54%

ASX 200 8,808.50 +0.00%

Sensex 77,123.58 -0.63%

Gold 4,031.20 +0.86%

Silver 58.42 +1.36%

Oil (WTI) 80.10 +2.51%

Brent 85.38 +2.50%

Copper 6.37 +2.23%

Gas Alam 2.87 -0.83%

Bitcoin 62,523.98 +0.46%

Ethereum 1,813.32 +2.25%

USD/IDR 18,097.00 +0.18%

EUR/USD 1.14 -0.09%

Daewoong Pharmaceutical

Daewoong Pharmaceutical Mengembangkan Niclosamide Sebagai Perawatan Twindemic

Redaksi • 30 November 2020

Latest Updates

Daewoong Pharmaceutical

18:00 WIB • 30 November 2020

Daewoong Pharmaceutical Mengembangkan Niclosamide Sebagai Perawatan Twindemic

Di tengah krisis COVID-19 yang berkepanjangan di seluruh dunia, kekhawatiran akan "twindemic" (epidemi ganda) semakin meluas.…